Any experts on biological pathway mapping based on genomic data sets?
These software-driven 'pathway analysis' links 'susceptability genes' with other clusters of similar genes involved in a particular pathway (e.g oxidative stress or cell-cell adhesion).
Question is, would these types of analysis be accurate at the protein level since most if not all data sets are derived from microarray or RT-PCR (i.e. genomic)?
Accuracy of ingenuity mapping?
No replies to this topic